Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Anthem Finally Walks Away From Cigna Merger, Seeks Charges

Published 05/14/2017, 10:01 PM

Anthem Inc. (NYSE:ANTM) has officially terminated its merger with Cigna Corp. (NYSE:CI) . This development came after the Delaware Chancery Judge refused Anthem’s request last week to hold back Cigna for another 60 days.

In January, Anthem postponed the merger date to April end to buy time. The company had hopes of the merger materializing under the Trump administration and planned to seek a quick appeal of the court decision that blocked it.

In February, Cigna filed a suit in Delaware Chancery Court asking to be freed from the deal and sought $1.85 billion of termination fee and $13 billion in other charges.

There was always a friction between the companies, with each blaming the other for the deal breakup. The fight has now reached a stage where the focus is on the breakup fee.

Anthem and Cigna were already in a rough patch. Since the very beginning, Anthem continued its pursuit of Cigna by creating pressure on its board members despite the latter’s repeated rejection of the takeover proposal.
Anthem was also ready to go public with its proposal offer if Cigna did not give consent to the deal. With time, the differences between the two companies have broadened and now the fight is in the open.

Since the announcement of the merger, shares of both Anthem and Cigna have underperformed the Zacks categorized Health Maintenance Organization industry by generating returns of 17.6% and 24%, respectively, compared with the sector’s gain of 31.8%. The share price performance of each of the players reflects the pessimism that surrounded their stocks following the merger-related uncertainty and investor perception that they may finally be blocked.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Anthem also charged Cigna for its coldness toward the merger and has alleged that its ways were aimed at sabotaging the deal. Anthem pointed out that Cigna’s conduct at each stage of the merger, right from its integration efforts to the appeals, reflected its reluctance to pursue and seal the deal.
Anthem blamed the company of improper use of its rights to terminate the merger. Therefore, per Anthem, Cigna is not entitled to a termination fee. Anthem on the other hand will charge Cigna of the massive damages it has suffered because of the non-completion of the deal.

Recently, another mega merger of Aetna Inc. (NYSE:AET) with Humana Inc. (NYSE:HUM) was also terminated and the termination fee was duly paid to the concerned party.

Both Cigna and Anthem carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

5 Trades Could Profit ""Big-League"" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



Cigna Corporation (CI): Free Stock Analysis Report

Aetna Inc. (AET): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.